Care line · Longevity & peptides
Longevity is what your audience buys next. Own it early.
NAD+, peptides, and optimization protocols: the fastest-growing premium category in consumer health, bought by the people who already buy everything else. EmbedCare runs the clinical side under your brand.
Licensed clinician
Longevity & Peptides visits
4.6/5 patient rating
Reviewed in 15–60 min
Why longevity & peptides earns its place
The premium frontier
Longevity buyers are the highest-spend, most-engaged segment in health, and the category is still being claimed.
Protocol-native retention
Cycles, stacks, and monitoring make longevity inherently subscription-shaped.
The halo line
Offering longevity repositions your whole brand upmarket. It sells the menu, not just itself.
The people
Licensed clinicians. Happy patients. Your brand between them.
Every longevity & peptides visit is reviewed by a licensed clinician, routed by state licensure and specialty in 15–60 minutes, around the clock. Patients rate the experience 4.6/5, under your brand, not ours.
“The protocol arrives with the plan attached: what to take, when, and what we're watching next cycle.”
Longevity program member · illustrativeBuilt for audiences like yours.
Med spas
Anti-aging clients are longevity buyers already.
For med spasGyms & fitness
Recovery and performance protocols fit the floor.
For gyms & fitnessCreators & media
The category defining premium health content.
For creators & mediaThey come for the protocol. They stay for hormones, weight, and primary care. Longevity buyers want one place that runs all of it.
Do the math on your audience.
Drag the slider to your reach. At a conservative 2% of people already buying this care, the recurring revenue is yours to keep; we charge flat product rates.
Revenue Engine
Adjust your audience size to see potential returns.
Modeled on a representative blended program mix across care lines. DTC GLP-1 subscriptions alone run ~$199/mo in the market. Illustrative estimate only; actual results vary with conversion, retention, pricing, and medication costs. Not guaranteed earnings.